Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Earnings momentum for Encore Capital Group, Inc. (ECPG - Snapshot Report) has been advancing since this debt service provider posted robust second quarter results in early August. Now, this Zacks #2 Rank (Buy) is scheduled to announce third-quarter results at the end of the month, having beaten earnings expectations in three out of the last four quarters. In addition, ECPG hit its 52-week high on September 18 and has a P/B ratio of just 1.7, making it an attractive value pick.
Earnings Recap
Encore Capital is expected to release third quarter earnings on October 29. The Zacks Consensus Estimates are for 79 cents per share on revenue of $144.0 million.
On August 2, Encore Capital Group announced second-quarter earnings per share of 82 cents, beating the Zacks Consensus Estimate of 71 cents by 15.5% and last years earnings of 58 cents by 41.4%. Results improved mainly due to a boost in the top line, partially offset by higher operating expenses.
Total revenue surged 27% year-over-year to $141.1 million. Nevertheless, total operating expenses on an adjusted basis rose 19% to $95.0 million on the back of higher salaries and employee benefits expense. Furthermore, EBITDA on an adjusted basis increased 28% from the prior-year quarter to $147.9 million.
As of June 30, 2012, Encore Capital Groups total assets were $1.2 billion and cash and cash equivalents stood at $15.0 million.
Earnings Momentum Advances
Over the last 60 days, the Zacks Consensus Estimate for 2012 improved 3.3% to $3.13 per share, implying year-over-year growth of 32.2%. For 2013, the Zacks Consensus Estimate rose 1.1% to $3.64 over the same time frame, representing year-over-year growth of 16.3%.
Reasonable Valuation
Along with a low P/B ratio, Encore Capital Group has a forward P/E multiple as low as 8.7 (a P/E ratio under 15.0 and a P/B ratio below 3.0 generally indicate value). The company has a trailing 12-month ROE of 18.8%, in line with the peer group average.
Moreover, given the long-term growth projection of 15.5%, the PEG ratio comes in at 0.58, a 42.0% discount to the benchmark of 1 for a fairly priced stock. Thus, the expected long-term earnings growth is currently priced at a discount.
Based in San Diego, California, Encore Capital is the provider of debt management and recovery solutions to consumers and property owners across a broad range of assets through its subsidiaries. The company purchases portfolios of defaulted customers receivables at steep discounts and uses a wide range of operational channels to maximize the collections from the portfolios. With a market capitalization of roughly $692.6 million, Encore Capital competes with Credit Acceptance Corp. (CACC) and Regional Management Corp. (RM), among others.
Want More of Our Best Recommendations?
Zacks' Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Then each week he hand-selects the most compelling trades and serves them up to you in a new program called Zacks Confidential.
Learn More>>
Get the full Snapshot Report on ECPG - FREE